QIAGEN and LabCorp deepen relationship with widespread use of bioinformatics solutions

QIAGEN launches novel NGS workflow for simultaneous DNA and RNA analysis for use in cancer profiling at 2019 AMP Annual Meeting

QIAGEN expands portfolio of immuno-oncology assets for future companion diagnostics and biomarkers

QIAGEN reports full results for third quarter and first nine months of 2019

QIAGEN’s QuantiFERON®-TB Gold Plus test added to the Global Drug Facility catalog for public health efforts

QIAGEN launches new QIAseq FastSelect solutions to accelerate RNAseq

QIAGEN reports preliminary Q3 2019 results and announces measures to prioritize resource allocation

QIAGEN announces CEO leadership transition

QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation (3)